Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hagin

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Journal of Clinical Immunology|June 8, 2021
Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-βDonald C Vinh, Laurent Abel, Paul Bastard, et al.
Annals of the Rheumatic Diseases|July 22, 2022
Immunogenicity induced by two and three doses of the BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic diseases and immunocompetent controls: a longitudinal multicentre studyVictoria Furer, Tali Eviatar, Tal Freund, et al.
Transplantation and Cellular Therapy|July 2, 2021
Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort StudyRon Ram, David Hagin, Nino Kikozashvilli, et al.
Journal of Clinical Immunology|October 7, 2022
Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced MyocarditisAlexandre Bolze, Trine H Mogensen, Shen-Ying Zhang, et al.
Journal of Clinical Immunology|August 27, 2017
Erratum to: Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary ImmunodeficienciesKathleen E Sullivan, Hamid Bassiri, Ahmed A Bousfiha, et al.
Journal of Clinical Immunology|August 9, 2017
Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary ImmunodeficienciesKathleen E Sullivan, Hamid Bassiri, Ahmed A Bousfiha, et al.
JAMA Neurology|October 7, 2024
Directly Isolated Allogeneic Virus-Specific T Cells in Progressive Multifocal LeukoencephalopathyNora Möhn, Lea Grote-Levi, Mike P Wattjes, et al.
Science Immunology|June 24, 2022
FOXP3 exon 2 controls T<sub>reg</sub> stability and autoimmunityJianguang Du, Qun Wang, Shuangshuang Yang, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 25, 2021
A Toolkit and Framework for Optimal Laboratory Evaluation of Individuals with Suspected Primary ImmunodeficiencyVijaya Knight, Jennifer R Heimall, Hey Chong, et al.
Blood|June 21, 2024
Genotype-phenotype correlations in chronic granulomatous disease: insights from a large national cohortBaruch Wolach, Ronit Gavrieli, Ofir Wolach, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Journal of Clinical Immunology|June 8, 2021
Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-βDonald C Vinh, Laurent Abel, Paul Bastard, et al.
Annals of the Rheumatic Diseases|July 22, 2022
Immunogenicity induced by two and three doses of the BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic diseases and immunocompetent controls: a longitudinal multicentre studyVictoria Furer, Tali Eviatar, Tal Freund, et al.
Transplantation and Cellular Therapy|July 2, 2021
Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy-A Single-Center Prospective Cohort StudyRon Ram, David Hagin, Nino Kikozashvilli, et al.
Journal of Clinical Immunology|October 7, 2022
Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced MyocarditisAlexandre Bolze, Trine H Mogensen, Shen-Ying Zhang, et al.
Journal of Clinical Immunology|August 27, 2017
Erratum to: Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary ImmunodeficienciesKathleen E Sullivan, Hamid Bassiri, Ahmed A Bousfiha, et al.
Journal of Clinical Immunology|August 9, 2017
Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary ImmunodeficienciesKathleen E Sullivan, Hamid Bassiri, Ahmed A Bousfiha, et al.
JAMA Neurology|October 7, 2024
Directly Isolated Allogeneic Virus-Specific T Cells in Progressive Multifocal LeukoencephalopathyNora Möhn, Lea Grote-Levi, Mike P Wattjes, et al.
Science Immunology|June 24, 2022
FOXP3 exon 2 controls T<sub>reg</sub> stability and autoimmunityJianguang Du, Qun Wang, Shuangshuang Yang, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 25, 2021
A Toolkit and Framework for Optimal Laboratory Evaluation of Individuals with Suspected Primary ImmunodeficiencyVijaya Knight, Jennifer R Heimall, Hey Chong, et al.
Blood|June 21, 2024
Genotype-phenotype correlations in chronic granulomatous disease: insights from a large national cohortBaruch Wolach, Ronit Gavrieli, Ofir Wolach, et al.
Pageof 10